Rein Therapeutics (RNTX) Other Gross PP&E Adjustments (2016 - 2025)
Rein Therapeutics (RNTX) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with -$401000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 23.18% to -$401000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Dec 2025, up 41.32% year-over-year, with the annual reading at -$401000.0 for FY2025, 23.18% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$401000.0 at Rein Therapeutics, down from -$255000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$192000.0 in Q4 2022, with the low at -$1.0 million in Q4 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$490000.0, with a median of -$472500.0 recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments soared 95.12% in 2021, then tumbled 155.13% in 2023.
- Over 5 years, Other Gross PP&E Adjustments stood at -$1.0 million in 2021, then surged by 81.59% to -$192000.0 in 2022, then tumbled by 43.75% to -$276000.0 in 2023, then plummeted by 89.13% to -$522000.0 in 2024, then rose by 23.18% to -$401000.0 in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$401000.0, -$255000.0, and -$349000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.